Literature DB >> 31281193

Canadian dog owners' use and perceptions of cannabis products.

Lori R Kogan1, Peter W Hellyer1, Sarah Silcox1, Regina Schoenfeld-Tacher1.   

Abstract

The legal market for recreational and medicinal cannabis for human consumption is growing worldwide. At the same time, marketing of cannabis products for use in pets is expanding. Yet, there is little research exploring the effects of cannabis use in veterinary medicine. This study used an anonymous, online survey to assess Canadian pet owners' reasons for purchasing cannabis products for their dogs, and their perceptions regarding efficacy of these treatments. Owners purchased cannabis products for treatment of pain, inflammation, and anxiety in dogs, and perceived these preparations to be equally or more effective than conventional medications. Most owners reported only minimal side effects in their dogs. Despite indicating comfort in discussing canine cannabis administration with their veterinarian, most owners relied on commercial websites for product information. The main reasons for choosing cannabis products were the ability to use as an adjuvant to other therapies, and the perception of it being a natural substance. Given this information, it is incumbent upon veterinarians to appropriately counsel their clients, and also to advocate for evidence-based studies to evaluate the efficacy of cannabis use in non-human species.

Entities:  

Mesh:

Year:  2019        PMID: 31281193      PMCID: PMC6563876     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  10 in total

Review 1.  A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.

Authors:  Vincenzo Di Marzo
Journal:  Trends Pharmacol Sci       Date:  2006-02-13       Impact factor: 14.819

2.  Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010).

Authors:  Stacy D Meola; Caitlin C Tearney; Sharlee A Haas; Timothy B Hackett; Elisa M Mazzaferro
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2012-12

3.  Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis.

Authors:  Luca Campora; Vincenzo Miragliotta; Emanuele Ricci; Luigia Cristino; Vincenzo Di Marzo; Francesco Albanese; Maria Federica Della Valle; Francesca Abramo
Journal:  Am J Vet Res       Date:  2012-07       Impact factor: 1.156

Review 4.  Marijuana poisoning.

Authors:  Kevin T Fitzgerald; Alvin C Bronstein; Kristin L Newquist
Journal:  Top Companion Anim Med       Date:  2013-02

Review 5.  Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.

Authors:  M E Lynch; Mark A Ware
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-22       Impact factor: 4.147

Review 6.  The therapeutic potential of cannabis and cannabinoids.

Authors:  Franjo Grotenhermen; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-07-23       Impact factor: 5.594

7.  Caregiver placebo effect for dogs with lameness from osteoarthritis.

Authors:  Michael G Conzemius; Richard B Evans
Journal:  J Am Vet Med Assoc       Date:  2012-11-15       Impact factor: 1.936

8.  Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder.

Authors:  Felix K Gesell; Alexander A Zoerner; Christina Brauer; Stefan Engeli; Dimitros Tsikas; Andrea Tipold
Journal:  BMC Vet Res       Date:  2013-12-26       Impact factor: 2.741

9.  Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study.

Authors:  Carmela Valastro; Debora Campanile; Mariarosaria Marinaro; Delia Franchini; Fabiana Piscitelli; Roberta Verde; Vincenzo Di Marzo; Antonio Di Bello
Journal:  BMC Vet Res       Date:  2017-11-06       Impact factor: 2.741

10.  Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.

Authors:  Lauri-Jo Gamble; Jordyn M Boesch; Christopher W Frye; Wayne S Schwark; Sabine Mann; Lisa Wolfe; Holly Brown; Erin S Berthelsen; Joseph J Wakshlag
Journal:  Front Vet Sci       Date:  2018-07-23
  10 in total
  5 in total

1.  Composition of unapproved cannabinoid products directly marketed to Canadian pet owners.

Authors:  Alan Chicoine; Stephanie Vuong; Kate Illing; Jonathan Hare; Jennifer Caldwell; Ian Sandler
Journal:  Can Vet J       Date:  2020-05       Impact factor: 1.008

2.  Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.

Authors:  Joseph J Wakshlag; Stephen Cital; Scott J Eaton; Reece Prussin; Christopher Hudalla
Journal:  Vet Med (Auckl)       Date:  2020-04-15

3.  Motivations and expectations for using cannabis products to treat pain in humans and dogs: a mixed methods study.

Authors:  Jean E Wallace; Lori R Kogan; Eloise C J Carr; Peter W Hellyer
Journal:  J Cannabis Res       Date:  2020-10-14

4.  Slovenian Pet Owners' Experience, Attitudes, and Predictors Regarding Cannabinoid Use in Dogs and Cats.

Authors:  Katerina Tomsič; Kristina Rakinić; Alenka Seliškar
Journal:  Front Vet Sci       Date:  2022-01-05

5.  Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America.

Authors:  Richard Quansah Amissah; Nadine A Vogt; Chuyun Chen; Karolina Urban; Jibran Khokhar
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.